1. Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling
   Jiahui Wu et al, 2022, Frontiers in Oncology CrossRef
2. ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer
   Zheng Liu et al, 2020, OncoImmunology CrossRef
3. Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
   Onat Kadioglu et al, 2018, Frontiers in Pharmacology CrossRef
4. Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR‐mutated NSCLC with high thrombospondin‐1 expression
   Naomi Onda et al, 2024, Cancer Science CrossRef